• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

TAKASHIMA HIROKI  高島 大輝

ORCIDConnect your ORCID iD *help
… Alternative Names

Takashima Hiroki  高島 大輝

Less
Researcher Number 10785588
Other IDs
Affiliation (Current) 2025: 国立研究開発法人国立がん研究センター, 先端医療開発センター, 研究員
Affiliation (based on the past Project Information) *help 2023 – 2024: 国立研究開発法人国立がん研究センター, 先端医療開発センター, 研究員
2022: 国立研究開発法人国立がん研究センター, 先端医療開発センター, ユニット長
2018 – 2020: 国立研究開発法人国立がん研究センター, 先端医療開発センター, 研究員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related
Except Principal Investigator
Sections That Are Subject to Joint Review: Basic Section47010:Pharmaceutical chemistry and drug development sciences-related , Basic Section47050:Environmental and natural pharmaceutical resources-related / Basic Section 47050:Environmental and natural pharmaceutical resources-related / Basic Section 47010:Pharmaceutical chemistry and drug development sciences-related
Keywords
Principal Investigator
Drug delivery system / 能動的標的化 / 抗体工学 / 放射線分解 / 毒性学 / 薬理学 / 抗体改変技術 / リンカー技術 / 放射免疫療法 / アスタチン-211 … More / ナノパーティクル / 武装抗体 / Drug Delivery System / HER2 / 組織因子 / 腫瘍内分布 / エピルビシン / 抗体付加抗がん剤内包ミセル / 抗体-薬物複合体 / 抗体 / Drug Delivery System … More
Except Principal Investigator
構造生物学 / 抗体依存性細胞傷害活性 / 糖鎖 / 抗体 Less
  • Research Projects

    (3 results)
  • Research Products

    (8 results)
  • Co-Researchers

    (4 People)
  •  系統的抗体糖鎖改変と有機合成糖鎖を用いた抗体機能強化

    • Principal Investigator
      眞鍋 史乃
    • Project Period (FY)
      2024 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 47010:Pharmaceutical chemistry and drug development sciences-related
      Basic Section 47050:Environmental and natural pharmaceutical resources-related
      Sections That Are Subject to Joint Review: Basic Section47010:Pharmaceutical chemistry and drug development sciences-related , Basic Section47050:Environmental and natural pharmaceutical resources-related
    • Research Institution
      Hoshi University
  •  Altered biodistribution of astatine-211 via linker technology and antibody engineering in radioimmunotherapyPrincipal Investigator

    • Principal Investigator
      Takashima Hiroki
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      National Cancer Center Japan
  •  Development of drug delivery systems using antibodyPrincipal Investigator

    • Principal Investigator
      Takashima Hiroki
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      National Cancer Center Japan

All 2023 2022 2020 2019

All Journal Article Presentation

  • [Journal Article] Tumor Targeting of 211At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis2023

    • Author(s)
      Takashima Hiroki、Ohnuki Kazunobu、Manabe Shino、Koga Yoshikatsu、Tsumura Ryo、Anzai Takahiro、Wang Yang、Yin Xiaojie、Sato Nozomi、Shigekawa Yudai、Nambu Akihiro、Usuda Sachiko、Haba Hiromitsu、Fujii Hirofumi、Yasunaga Masahiro
    • Journal Title

      Molecular Pharmaceutics

      Volume: 20 Issue: 2 Pages: 1156-1167

    • DOI

      10.1021/acs.molpharmaceut.2c00869

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K15594, KAKENHI-PLANNED-22H05024, KAKENHI-PROJECT-20K14500, KAKENHI-PROJECT-19H03357
  • [Journal Article] Reinforcement of antitumor effect of micelles containing anticancer drugs by binding of an anti-tissue factor antibody without direct cytocidal effects2020

    • Author(s)
      Takashima Hiroki、Koga Yoshikatsu、Tsumura Ryo、Yasunaga Masahiro、Tsuchiya Masami、Inoue Tadashi、Negishi Eriko、Harada Mitsunori、Yoshida Sei、Matsumura Yasuhiro
    • Journal Title

      Journal of Controlled Release

      Volume: 323 Pages: 138-150

    • DOI

      10.1016/j.jconrel.2020.03.048

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K15297
  • [Journal Article] Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models2019

    • Author(s)
      Tsumura Ryo、Manabe Shino、Takashima Hiroki、Koga Yoshikatsu、Yasunaga Masahiro、Matsumura Yasuhiro
    • Journal Title

      Cancer Science

      Volume: 110 Issue: 10 Pages: 3296-3305

    • DOI

      10.1111/cas.14146

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K15297, KAKENHI-PROJECT-18K14931
  • [Journal Article] Preclinical studies of immunomicelles incorporating anticancer drugs2019

    • Author(s)
      Takashima Hiroki、Tsumura Ryo、Koga Yoshikatsu、Yasunaga Masahiro、Harada Mitsunori、Matsumura Yasuhiro
    • Journal Title

      Drug Delivery System

      Volume: 34 Issue: 1 Pages: 29-37

    • DOI

      10.2745/dds.34.29

    • NAID

      130007636842

    • ISSN
      0913-5006, 1881-2732
    • Year and Date
      2019-01-25
    • Language
      Japanese
    • Data Source
      KAKENHI-PROJECT-18K15297
  • [Journal Article] Anti-tissue factor antibody?mediated immuno?SPECT imaging of tissue factor expression in mouse models of pancreatic cancer2019

    • Author(s)
      Sugyo Aya、Aung Winn、Tsuji Atsushi、Sudo Hitomi、Takashima Hiroki、Yasunaga Masahiro、Matsumura Yasuhiro、Saga Tsuneo、Higashi Tatsuya
    • Journal Title

      Oncology Reports

      Volume: 41 (4) Pages: 2371-2378

    • DOI

      10.3892/or.2019.7017

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K10460, KAKENHI-PROJECT-18K15297, KAKENHI-PROJECT-18H02774, KAKENHI-PROJECT-17K10497
  • [Presentation] Sodium ascorbate protection against radiolysis is indispensable to maintain active targeting of <sup>211</sup>At-labeled antibody2022

    • Author(s)
      Hiroki Takashima, Kazunobu Ohnuki, Shino Manabe, Yoshikatsu Koga, Ryo Tsumura, Takahiro Anzai, Yang Wang, Xiaojie Yin, Nozomi Sato, Yudai Shigekawa, Akihiro Nambu, Sachiko Usuda, Hiromitsu Haba, Hirofumi Fuji, Masahiro Yasunaga
    • Organizer
      第81回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-22K15594
  • [Presentation] Development of micelles containing anticancer drugs conjugated with an anti-tissue factor antibody without direct cytocidal effects2020

    • Author(s)
      Hiroki Takashima, Yoshikatsu Koga, Ryo Tsumura, Masahiro Yasunaga, Masami Tsuchiya, Tadashi Inoue, Eriko Negish, Chihiro Tanabe, Mitsunori Harada, Sei Yoshida, Yasuhiro Matsumura
    • Organizer
      2020 Controlled Release Society Virtual Annual Meeting
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K15297
  • [Presentation] Antitumor effect of nanomicelles conjugated to an anti-tissue factor antibody without a direct cytocidal effect2020

    • Author(s)
      Hiroki Takashima, Yoshikatsu Koga, Ryo Tsumura, Masami Tsuchiya, Tadashi Inoue, Eriko Negishi, Mitsunori Harada, Sei Yoshida, Yasuhiro Matsumura, Masahiro Yasunaga
    • Organizer
      第79回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-18K15297
  • 1.  眞鍋 史乃 (60300901)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 2.  加藤 晃一 (20211849)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  Hiranyakorn Methanee (60966133)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  U・WINN Aung
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi